The combination of Ibuprofen and Pseudoephedrine is generally applied in contexts where short-term symptomatic assistance is appropriate for conditions associated with the common cold and flu. This combination is commonly used across conditions presenting with acute episodes where multiple symptoms occur together, and supportive relief is needed.

This medication is relevant for easing symptoms related to systemic imbalance and physical discomfort, primarily targeting symptoms such as headache, general body aches, fever, nasal congestion, and sinus pressure. This combination is considered relevant for managing these manifestations when they lead to temporary functional strain.

“The medication is applied in scenarios where additional management of discomfort is required to address pain and symptoms related to nasal obstruction.”

It provides support that helps ease the overall symptom burden, assisting patients with coping more steadily during difficult episodes marked by temporary physiological imbalance. This offers a practical benefit by contributing to nasal decongestion, which is relevant when acute manifestations interfere with rest and function.

Quick Fact: Relief for Congestion
This combination is commonly used to help with nasal congestion and sinus pressure, symptoms that can interfere with sleep and daily routine.

Regulatory References

1. HPRA Summary of Product Characteristics

Who Can and Cannot Use Nurofen Rhume?

Official regulatory documentation establishes strict population eligibility for Nurofen Rhume (Ibuprofen / Pseudoephedrine). The medicine is approved for adults and adolescents aged 12 years and older.

The medicine is contraindicated for a number of populations and conditions, including:

• Age Restriction: Children under 12 years of age.
• Physiological State: Women in the last trimester of pregnancy and breast-feeding mothers.
• Comorbidities: Patients with a history of active or recurrent peptic ulcer/haemorrhage, or known hypersensitivity to Ibuprofen, Pseudoephedrine, or any NSAID.
• Organ/System Failure: Individuals with severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic insufficiency.
• Cardiovascular Conditions: Patients with severe hypertension, a history of stroke, or receiving Monoamine Oxidase Inhibitors (MAOIs).

Use is not recommended during the first and second trimesters of pregnancy. Furthermore, use requires special caution in the elderly due to increased adverse reaction risk, and in patients with certain conditions like Systemic Lupus Erythematosus (SLE) or controlled cardiovascular diseases.

Interactions with other medicines and products

Nurofen Rhume, a fixed-dose combination of Ibuprofen (an NSAID) and Pseudoephedrine (a sympathomimetic amine), has officially documented interaction profiles governed by both components.

---

Prohibited Combinations

Certain substance combinations are formally contraindicated in regulatory labeling due to the risk of severe adverse outcomes:

• Monoamine Oxidase Inhibitors (MAOIs): Use is prohibited concurrently or within 14 days of stopping MAOI therapy due to the risk of hypertensive crisis.
• Other Non-Steroidal Anti-inflammatory Drugs (NSAIDs): Co-administration, including with COX-2 inhibitors, is contraindicated due to an additive risk of gastrointestinal (GI) bleeding and ulceration.
• Other Sympathomimetic Decongestants: Other oral or nasal sympathomimetic agents are prohibited due to the risk of additive cardiovascular effects.

---

Clinically Significant Interactions

Interactions that require caution and monitoring as described in regulatory documents:

• Anticoagulants (e.g., Warfarin): Increased risk of severe hemorrhage due to the Ibuprofen component.
• Antihypertensives: May diminish the desired hypotensive effect of medicines like ACE Inhibitors and Diuretics.
• Lithium and Methotrexate: Ibuprofen may decrease the renal clearance of Lithium, leading to increased plasma concentrations, and may increase the plasma levels of Methotrexate.
• Acetylsalicylic Acid (Aspirin le 75 mg): Ibuprofen may competitively interfere with the anti-aggregating effect of low-dose Aspirin.

Administration Restrictions

Alcohol must be avoided during treatment due to the increased risk of GI bleeding. A mandatory timing rule applies to Mifepristone, requiring Ibuprofen to be withheld for 8–12 days after its administration. Furthermore, the risk of renal complications is heightened in vulnerable populations, such as the elderly or those with renal impairment, when this product is combined with Antihypertensives and Diuretics.

The product contains two active pharmaceutical ingredients: Ibuprofen and Pseudoephedrine.

Ibuprofen exerts its action by inhibiting the cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. This non-selective inhibition results in a subsequent reduction in the cellular biosynthesis of pro-inflammatory prostaglandins, which are lipid mediators of physiological signaling cascades.

Pseudoephedrine functions as a sympathomimetic agent, targeting vascular smooth muscle. It acts as an agonist, stimulating the alpha1-adrenergic receptors present on blood vessels within the nasal mucosa. This receptor stimulation induces vasoconstriction, which modulates the microcirculation by reducing local blood flow and associated tissue fluid dynamics.

The combined action modulates both prostaglandin production and nasal mucosal microvascular tone, representing a dual pharmacological mechanism.

The administration of Nurofen Rhume, a fixed-dose combination containing Ibuprofen 200 mg and Pseudoephedrine hydrochloride 30 mg, is defined by standards governing the route, dosage, and duration of use. The official route of administration is oral, using the film-coated tablet or capsule formulation. The core administrative principle is to employ the lowest effective dose for the shortest duration necessary.

---

Standard Regimen and Limits

Use Parameter	Official Labeled Instruction
Dosing for Adults/Adolescents (12+)	Initial dose of one to two tablets (200/30 mg to 400/60 mg FDC).
Dosing Frequency	Doses may be repeated every four to six hours; a minimum interval of four hours must be observed.
Maximum Daily Dose	The total intake must not exceed six tablets (1200 mg Ibuprofen / 180 mg Pseudoephedrine) in any 24-hour period.
Duration of Use	Mandated for short-term use only; typically limited to 10 days for adults or 3 days for adolescents (12-18 years).

---

The tablets are to be swallowed whole with water, and administration with or after food is permitted to reduce the potential for gastric irritation. Use of this combination product is not permitted for children under 12 years of age. The procedural constraints emphasize that the stated maximum daily dose must be strictly adhered to and not exceeded under any circumstances.

Research evidence / Overview of Studies for Nurofen Rhume

---

Evidence for Symptomatic Relief of Common Cold and Flu

The research base for the Ibuprofen and Pseudoephedrine fixed-dose combination consists primarily of Randomized Controlled Trials (RCTs). These studies are a common design for evaluating outcomes related to symptom change, such as headache, fever, and nasal congestion. Trials frequently compared the combination against a placebo or against using each active ingredient alone.

---

Study Structure and Comparator Evidence

Research explored the onset of symptom score changes and monitored the time point when measurable differences in patient-reported discomfort were observed. This comparative evidence provides information on symptom patterns when receiving the combined treatment versus a single ingredient. Bioequivalence studies were also conducted to establish the basis for the fixed-dose formulation.

---

Short-Term Focus and Extended-Duration Follow-up

The clinical investigation for this type of acute treatment typically involves short-term follow-up durations, with endpoints evaluated over periods ranging from a single dose up to a few days. As a result, long-term data are not available. There is limited information regarding the repeated or sustained use of the combination, as research is restricted to the acute phase.

---

Evidence in Specific Population Groups

The populations studied in the main clinical investigations were primarily adults and adolescents (typically aged 12 years and older). Research examined patterns of symptom change in these age groups. However, data for certain groups, such as those under 12 or individuals over 65 (geriatric populations), remain limited. The results apply only to the populations studied; combined data for patients with certain comorbidities also remain limited.

---

Identified Evidence Gaps and Areas for Further Research

Regulatory reviews highlight that the research monitors short-term changes, focusing specifically on symptom measurement rather than the underlying illness itself. The number of participants and follow-up durations were restricted to the acute phase. The primary outcomes studied were subjective measures of symptom change; the research data do not cover outcomes related to the underlying duration or progression of the cold or flu itself. Comparative evidence against other multi-symptom cold medications is also lacking.

Common questions about Nurofen Rhume (FAQ)

---

Q: What is the main difference between Nurofen Rhume and regular Nurofen (ibuprofen)?

A: According to official product information, Nurofen Rhume is a fixed-dose combination medicine. This means it contains two distinct active ingredients: Ibuprofen, which acts as a painkiller and fever reducer, and Pseudoephedrine, which works as a nasal decongestant. In contrast, standard regular Nurofen typically contains only Ibuprofen.

Q: Does Nurofen Rhume contain paracetamol?

A: The active ingredients listed in the regulatory documents for this fixed-dose product are strictly Ibuprofen and Pseudoephedrine hydrochloride. Official compositional information confirms that Nurofen Rhume does not contain paracetamol.

Q: Is it true that Nurofen Rhume should be taken with food?

A: Regulatory documents state that administration with or after food is permitted. This allowance is primarily to help reduce the potential for gastric irritation associated with the ibuprofen component. However, regulatory information describes taking it with food as permissible, not mandatory.

Q: Is the ibuprofen component in Nurofen Rhume the same strength as regular pills?

A: The Ibuprofen content in each fixed-dose tablet is typically 200 mg. This is a common dosage strength often found in standard single-ingredient Ibuprofen tablets available over the counter.

Q: Are there child-specific formulations of Nurofen Rhume available?

A: Official eligibility guidelines state that this combination medicine is contraindicated for children under 12 years of age. Therefore, there are no child-specific formulations of the Ibuprofen/Pseudoephedrine fixed-dose combination available for this younger age group.

Q: Is Nurofen Rhume mainly for a blocked nose or for pain?

A: Official labeling describes the product's therapeutic purpose as providing symptomatic relief for the primary discomforts of cold and flu. This dual purpose includes targeting both systemic pain, such as headache and fever, and localized symptoms like a blocked nose or sinus congestion.

Q: Why does Nurofen Rhume sometimes cause a feeling of restlessness?

A: The Pseudoephedrine component is a sympathomimetic agent, and regulatory documents list potential side effects that affect the nervous system. These undesirable effects can include feelings of restlessness, insomnia (trouble sleeping), and anxiety.

Q: Does Nurofen Rhume help with sinus headaches?

A: The general therapeutic purpose, as documented in regulatory sources, is the relief of both headache and symptoms related to sinus congestion. Therefore, the combined action of the ingredients is consistent with targeting the discomfort of a sinus headache.

Q: Can Nurofen Rhume cause high blood pressure?

A: Official documents list Hypertension (high blood pressure) as a potential undesirable effect in the adverse events profile, often categorized as 'Not Known' frequency. It is also contraindicated for patients who already have severe or uncontrolled high blood pressure.

Q: What kind of research exists to support the use of Nurofen Rhume for cold symptoms?

A: The research evidence used in regulatory reviews primarily comes from Randomized Controlled Trials (RCTs). These studies typically compare the combination product against a placebo or the single ingredients to measure the onset and changes in symptom scores, such as fever, headache, and nasal congestion relief.

Q: Can Nurofen Rhume be used for allergies as well as a cold?

A: The specific therapeutic indication for this product is for the symptomatic relief of cold and flu discomforts. Use for symptoms strictly related to allergies is not listed in the standard regulatory indications.

Q: Is it common to feel dizzy after taking Nurofen Rhume?

A: Official documents list Dizziness as a possible undesirable effect, which is typically noted under the less frequent or 'Not Known' frequency categories in the adverse event profile.

Q: Does Nurofen Rhume affect sleep?

A: Official safety information lists Insomnia (difficulty sleeping) as a possible undesirable effect. This is associated with the Pseudoephedrine component, which is a stimulant.

Q: What is the recommended storage temperature for Nurofen Rhume?

A: Regulatory requirements state the product must be stored below 25 C (or 30 C depending on the formulation) and kept in its original packaging. It is mandatory that the medicine is always stored out of the sight and reach of children.

Q: Are there any ingredients in Nurofen Rhume that are banned in certain sports?

A: The decongestant component, Pseudoephedrine, is listed on the World Anti-Doping Agency (WADA) Prohibited List. It is classified as a specified stimulant and is included on the Prohibited List for use in-competition above certain concentration thresholds.

Q: What are the signs of an overdose of Nurofen Rhume?

A: Official overdose information describes potential symptoms from the two active ingredients, which may include effects on the central nervous and gastrointestinal systems, such as severe headache, agitation, confusion, or bleeding.

Q: Is Nurofen Rhume effective for sore throat pain?

A: The therapeutic purpose listed in regulatory documents covers the symptomatic relief of pain and headache associated with cold and flu. The specific mention of sore throat pain is covered within the broader relief of pain provided by the Ibuprofen component.

Q: Do you need a prescription to buy Nurofen Rhume in most places?

A: Official categorization for this product in many regions places it as an Over-the-Counter (OTC) medicine. This classification means it is generally accessible for individuals seeking self-treatment for common cold discomforts without needing a prescription.

Q: Is there a known link between Nurofen Rhume and kidney problems?

A: Regulatory documents report the risk of Acute renal failure and renal insufficiency (kidney problems) as a very rare or 'Not Known' frequency undesirable effect, especially in long-term use. Official documents state the product is contraindicated for individuals who already have severe kidney failure.

Q: Does Nurofen Rhume contain antihistamines?

A: The product's composition is clearly listed as containing the active ingredients Ibuprofen and Pseudoephedrine hydrochloride. Official compositional information confirms that Nurofen Rhume does not contain antihistamines.

Q: What is the risk of dependence associated with Nurofen Rhume?

A: Regulatory information notes that the Pseudoephedrine component carries a potential for misuse or intentional abuse for its stimulant effects. This potential can lead to the development of tolerance and dependency, particularly if the product is used for prolonged periods beyond the labeled duration.

Q: Is there a specific way to dispose of expired Nurofen Rhume?

A: Official disposal guidance mandates that any unused or expired medicine must be handled in accordance with local requirements. It should never be thrown away via wastewater or general household waste to ensure proper environmental handling.

Q: Does Nurofen Rhume cause constipation?

A: Official safety documents list constipation as a possible undesirable effect of the medicine. It is typically categorized under the uncommon frequency of gastrointestinal disorders.

Q: Are there different strengths of Nurofen Rhume tablets?

A: The standard fixed-dose combination product is the tablet containing Ibuprofen 200 mg and Pseudoephedrine hydrochloride 30 mg. Regulatory information does not typically list other available strengths for this specific fixed-dose formulation.

Q: Can Nurofen Rhume interfere with birth control pills?

A: Some regulatory reviews have noted that the NSAID (ibuprofen) component may be associated with a small increased risk of blood clots (VTE) when used alongside certain hormonal contraceptives. This potential risk is a factor considered when regulatory agencies apply short-term use guidelines.

Q: Why do some people report feeling more anxious after taking Nurofen Rhume?

A: Official documents list anxiety as a possible undesirable effect associated with the product. This effect is generally attributed to the stimulant properties of the Pseudoephedrine component.

Q: Is it possible to develop a tolerance to the decongestant effect of Nurofen Rhume?

A: The Pseudoephedrine component, which is responsible for the decongestant effect, has been noted in regulatory reviews to have a potential for tolerance to develop. This risk is typically associated with repeated or extended use.

How to Store and Dispose of Nurofen Rhume?

Regulatory documents outline specific requirements for the storage and final disposal of Nurofen Rhume.

---

Official Storage Requirements

• Temperature: The product must be stored below 25 C (some formulations permit up to 30 C).
• Protection: It is mandatory to store the medicine in the original package to protect it from moisture and keep it in a dry place.
• Child Safety: The product must be stored out of the sight and reach of children.
• Shelf-Life: Do not use the medicine after the expiration date printed on the packaging.

---

Disposal Instructions

Any unused or expired Nurofen Rhume must be disposed of in accordance with local requirements. The medicine should not be thrown away via wastewater or general household waste to ensure proper environmental handling, as specified in regulatory guidance.